Park National director reports 345-share grant under 2017 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Park National Corp (PRK): Form 4 insider transaction. Director F. W. Englefield IV reported an equity award of 345 common shares on 10/27/2025, coded “A” (grant/acquisition), at a stated price of $0. The award was made under the Park National Corporation 2017 Long‑Term Incentive Plan for Non‑Employee Directors.
Following the transaction, Englefield directly beneficially owns 8,985 common shares. Indirect holdings include 54 shares as Trustee of the Anthony J Englefield Trust and 53 shares as Trustee of the Janet Englefield Trust fbo Anthony J Englefield.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
ENGLEFIELD F W IV
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 345 | $0.00 | -- |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Holdings After Transaction:
Common Shares — 8,985 shares (Direct);
Common Shares — 54 shares (Indirect, F. W. Englefield IV, Trustee of Anthony J Englefield Trust)
Footnotes (1)
- [object Object]
FAQ
What did PRK disclose on this Form 4?
A director, F. W. Englefield IV, reported an award of 345 common shares on 10/27/2025 under the 2017 Non‑Employee Directors LTIP.
What was the transaction code and price for PRK?
The transaction code was A (grant/acquisition), and the stated price was $0.
Does the PRK director have indirect holdings?
Yes. 54 shares as Trustee of the Anthony J Englefield Trust and 53 shares as Trustee of the Janet Englefield Trust fbo Anthony J Englefield.
What is the reporting person’s relationship to PRK?
The reporting person is a Director of Park National Corp.